Cargando…

Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing

Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heteroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Sijia, McGranahan, Nicholas, Gao, Jing, Chen, Peng, Jiang, Wei, Yang, Lingrong, Ma, Li, Liao, Junfang, Xie, Tian, Xie, Congying, Enver, Tariq, Wu, Shixiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938262/
https://www.ncbi.nlm.nih.gov/pubmed/36807354
http://dx.doi.org/10.1038/s41467-023-36558-1
_version_ 1784890592027738112
author Cui, Sijia
McGranahan, Nicholas
Gao, Jing
Chen, Peng
Jiang, Wei
Yang, Lingrong
Ma, Li
Liao, Junfang
Xie, Tian
Xie, Congying
Enver, Tariq
Wu, Shixiu
author_facet Cui, Sijia
McGranahan, Nicholas
Gao, Jing
Chen, Peng
Jiang, Wei
Yang, Lingrong
Ma, Li
Liao, Junfang
Xie, Tian
Xie, Congying
Enver, Tariq
Wu, Shixiu
author_sort Cui, Sijia
collection PubMed
description Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a selective force to shape the clonal evolution of ESCC is unclear. In this study, we perform multi-omic sequencing on 186 samples from 36 primary ESCC patients. Through multi-omics analyses, it is discovered that genomic, epigenomic, and transcriptomic ITH are underpinned by ongoing chromosomal instability. Based on the RNA-seq data, we observe diverse levels of immune infiltrate across different tumor sites from the same tumor. We reveal genetic mechanisms of neoantigen evasion under distinct selection pressure from the diverse immune microenvironment. Overall, our work offers an avenue of dissecting the complex contribution of the multi-omics level to the ITH in ESCC and thereby enhances the development of clinical therapy.
format Online
Article
Text
id pubmed-9938262
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99382622023-02-19 Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing Cui, Sijia McGranahan, Nicholas Gao, Jing Chen, Peng Jiang, Wei Yang, Lingrong Ma, Li Liao, Junfang Xie, Tian Xie, Congying Enver, Tariq Wu, Shixiu Nat Commun Article Intratumoral heterogeneity (ITH) has been linked to decreased efficacy of clinical treatments. However, although genomic ITH has been characterized in genetic, transcriptomic and epigenetic alterations are hallmarks of esophageal squamous cell carcinoma (ESCC), the extent to which these are heterogeneous in ESCC has not been explored in a unified framework. Further, the extent to which tumor-infiltrated T lymphocytes are directed against cancer cells, but how the immune infiltration acts as a selective force to shape the clonal evolution of ESCC is unclear. In this study, we perform multi-omic sequencing on 186 samples from 36 primary ESCC patients. Through multi-omics analyses, it is discovered that genomic, epigenomic, and transcriptomic ITH are underpinned by ongoing chromosomal instability. Based on the RNA-seq data, we observe diverse levels of immune infiltrate across different tumor sites from the same tumor. We reveal genetic mechanisms of neoantigen evasion under distinct selection pressure from the diverse immune microenvironment. Overall, our work offers an avenue of dissecting the complex contribution of the multi-omics level to the ITH in ESCC and thereby enhances the development of clinical therapy. Nature Publishing Group UK 2023-02-17 /pmc/articles/PMC9938262/ /pubmed/36807354 http://dx.doi.org/10.1038/s41467-023-36558-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Cui, Sijia
McGranahan, Nicholas
Gao, Jing
Chen, Peng
Jiang, Wei
Yang, Lingrong
Ma, Li
Liao, Junfang
Xie, Tian
Xie, Congying
Enver, Tariq
Wu, Shixiu
Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
title Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
title_full Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
title_fullStr Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
title_full_unstemmed Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
title_short Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
title_sort tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938262/
https://www.ncbi.nlm.nih.gov/pubmed/36807354
http://dx.doi.org/10.1038/s41467-023-36558-1
work_keys_str_mv AT cuisijia trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT mcgranahannicholas trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT gaojing trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT chenpeng trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT jiangwei trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT yanglingrong trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT mali trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT liaojunfang trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT xietian trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT xiecongying trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT envertariq trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing
AT wushixiu trackingtheevolutionofesophagealsquamouscellcarcinomaunderdynamicimmuneselectionbymultiomicssequencing